These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

420 related items for PubMed ID: 12370860

  • 61. Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone + arginine as provocative tests for the diagnosis of GH deficiency in adults.
    Aimaretti G, Corneli G, Razzore P, Bellone S, Baffoni C, Arvat E, Camanni F, Ghigo E.
    J Clin Endocrinol Metab; 1998 May; 83(5):1615-8. PubMed ID: 9589665
    [Abstract] [Full Text] [Related]

  • 62. Impaired cardiac performance in elderly patients with growth hormone deficiency.
    Colao A, Cuocolo A, Di Somma C, Cerbone G, Della Morte AM, Nicolai E, Lucci R, Salvatore M, Lombardi G.
    J Clin Endocrinol Metab; 1999 Nov; 84(11):3950-5. PubMed ID: 10566633
    [Abstract] [Full Text] [Related]

  • 63. Different degrees of GH deficiency evidenced by GHRH+arginine test and IGF-I levels in adults with pituritary disease.
    Aimaretti G, Corneli G, Di Somma C, Baldelli R, Gasco V, Rovere S, Migliaretti G, Colao A, Tamburrano G, Lombardi G, Ghigo E, Camanni F.
    J Endocrinol Invest; 2005 Mar; 28(3):247-52. PubMed ID: 15952410
    [Abstract] [Full Text] [Related]

  • 64. Growth hormone response to growth hormone-releasing hormone varies with the hypothalamic-pituitary abnormalities.
    Maghnie M, Moretta A, Valtorta A, Larizza D, Sayegh M, Greco AM, Castoldi E, Severi F.
    Eur J Endocrinol; 1996 Aug; 135(2):198-204. PubMed ID: 8810733
    [Abstract] [Full Text] [Related]

  • 65.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 66.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 67. Impaired GH secretion to provocative stimuli in two families with hypocalciuric hypercalcaemia.
    Cecconi E, Bogazzi F, Cetani F, Grasso L, Marcocci C, Genovesi M, Procopio M, Gasperi M, Pinchera A, Ghigo E, Martino E.
    Clin Endocrinol (Oxf); 2003 Nov; 59(5):604-6. PubMed ID: 14616884
    [Abstract] [Full Text] [Related]

  • 68.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 69.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 70. Diagnosis of growth hormone deficiency after pituitary surgery: the combined acipimox/GH-releasing hormone test.
    van Dam PS, Dieguez C, Cordido F, de Vries WR, Veldhuyzen BF, van Thiel E, Casanueva FF, Koppeschaar HP.
    Clin Endocrinol (Oxf); 2003 Feb; 58(2):156-62. PubMed ID: 12580930
    [Abstract] [Full Text] [Related]

  • 71. Hypothalamic/pituitary-axis of the spontaneous dwarf rat: autofeedback regulation of growth hormone (GH) includes suppression of GH releasing-hormone receptor messenger ribonucleic acid.
    Kamegai J, Unterman TG, Frohman LA, Kineman RD.
    Endocrinology; 1998 Aug; 139(8):3554-60. PubMed ID: 9681507
    [Abstract] [Full Text] [Related]

  • 72. Preservation of GHRH and GH-releasing peptide-2 efficacy in young men with experimentally induced hypogonadism.
    Veldhuis JD, Keenan DM, Bailey JN, Miles JM, Bowers CY.
    Eur J Endocrinol; 2009 Aug; 161(2):293-300. PubMed ID: 19458139
    [Abstract] [Full Text] [Related]

  • 73. Growth hormone/insulin-like growth factor-1 response to acute and chronic growth hormone-releasing peptide-2, growth hormone-releasing hormone 1-44NH2 and in combination in older men and women with decreased growth hormone secretion.
    Bowers CY, Granda-Ayala R.
    Endocrine; 2001 Feb; 14(1):79-86. PubMed ID: 11322505
    [Abstract] [Full Text] [Related]

  • 74. Arginine potentiates but does not restore the blunted growth hormone response to growth hormone-releasing hormone in obesity.
    Ghigo E, Procopio M, Boffano GM, Arvat E, Valente F, Maccario M, Mazza E, Camanni F.
    Metabolism; 1992 May; 41(5):560-3. PubMed ID: 1588839
    [Abstract] [Full Text] [Related]

  • 75.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 76.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 77. Activity of GH/IGF-I axis in patients with dilated cardiomyopathy.
    Broglio F, Fubini A, Morello M, Arvat E, Aimaretti G, Gianotti L, Boghen MF, Deghenghi R, Mangiardi L, Ghigo E.
    Clin Endocrinol (Oxf); 1999 Apr; 50(4):417-30. PubMed ID: 10468900
    [Abstract] [Full Text] [Related]

  • 78. Characteristics of adult patients with growth hormone deficiency who underwent neurosurgery for functioning and non-functioning pituitary adenomas and craniopharyngiomas.
    Baldelli R, Bianchi A, Diacono F, Passeri M, Fusco A, Valle D, Poggi M, Terlini M, Toscano V, Tamburrano G, Pontecorvi A, Maira G, De Marinis L.
    J Endocrinol Invest; 2005 Feb; 28(2):157-61. PubMed ID: 15887862
    [Abstract] [Full Text] [Related]

  • 79. Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life.
    Aguiar-Oliveira MH, Gill MS, de A Barretto ES, Alcântara MR, Miraki-Moud F, Menezes CA, Souza AH, Martinelli CE, Pereira FA, Salvatori R, Levine MA, Shalet SM, Camacho-Hubner C, Clayton PE.
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4118-26. PubMed ID: 10566659
    [Abstract] [Full Text] [Related]

  • 80. Growth hormone (GH) response to GH-releasing peptide-6 and GH-releasing hormone in normal-weight and overweight patients with non-insulin-dependent diabetes mellitus.
    Micić D, Macut D, Popović V, Kendereski A, Sumarac-Dumanović M, Zorić S, Dieguez C, Casanueva FF.
    Metabolism; 1999 Apr; 48(4):525-30. PubMed ID: 10206449
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.